Similar Articles |
|
Pharmaceutical Executive November 1, 2013 |
Roundtable on Market Access Market Access is a window on what matters in the real world of soaring patient expectations and crimped payer budgets for innovation. |
Managed Care January 2005 Maureen Glabman |
Health Plans Strain To Contain Rapidly Rising Cost of Imaging PET, CT, MRI -- these and other imaging technologies are valuable but costly. Aetna, Cigna, and a few other plans lead in clamping down on unnecessary use. |
Pharmaceutical Executive September 1, 2011 Don Creighton |
Bridging the Hidden Hurdle in Cancer Cures Diagnostics can boast the efficacy of drug treatments, but delivering the promise depends on a predictable pathway to reimbursement. |
Financial Planning April 1, 2007 Leif Wellington Haase |
To Our Health With healthcare costs continuing to spiral out of control, it's time for Americans to take a serious look at solutions. |
Pharmaceutical Executive February 1, 2006 Bryan Luce |
Back Page: Taking Hold of the Wheel Healthcare decision makers do not consistently consider drugs' value. FDA needs to be pressured to change its stance on communicating economic evidence. |
Managed Care April 2004 John Carroll |
$50M for Drug Comparisons Could Produce Valuable Results The Medicare amendment adopted late last year contains a provision that could help P&T committees, not to mention consumers, evaluate competing drugs. |
Managed Care March 2002 Mildred Beam-Rucker |
'Team Approach' to Contract Talks Means That Nobody Feels Cheated Managed care is a business. Both parties want a profitable relationship, and while profitability is important, providers and managed care organizations seem to have more success when they identify a joint mission for the relationship and take a team approach to contracting... |
Managed Care October 2003 Martin Sipkoff |
Pain Management: Health Plans Need to Take Control Insurers have not focused much on chronic pain. They should. It presents a humanitarian and business opportunity. |
Managed Care March 2007 |
Harvard Study Endorses Value-Based Insurance Design A new study shows that employers and other payers who are designing health benefits should make cost-effective treatments free or low-cost for patients and charge more for less cost-effective alternative treatments. |
Inc. December 2003 Noel Weyrich |
The Worst Business in America Suppose you couldn't raise prices, you couldn't control expenses, and you were morally obligated to meet the needs of customers who are eager to sue if anything goes wrong. Suppose you were a group of doctors trying to birth babies in the 21st century. |
Managed Care September 1999 Bruce J. Goldstein, J.D. & Mark D. Abruzzo, J.D. |
Health Plans That Decredential Docs Must Do It Correctly and Expect a Fight |